SEC Tracker
Get the app

HeartSciences HSCS

HeartSciences gets FDA clearance for MyoVista device

Additional proxy materials

Form
DEFA14A
Filed
Importance
Routine
  1. FDA granted 510(k) clearance (K260005) for MyoVista wavECG device
  2. Clearance covers ECG signal acquisition and interpretation for adult and pediatric patients
  3. Device does not include AI-ECG algorithm
  4. Company plans to evaluate device and IP options

Written from the DEFA14A on EDGAR. Check the filing before you rely on it.

Open in the appGet the appView on EDGAR

Get an email when HeartSciences files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 6199 and related industry codes: the same peer list as the financial tables.

  1. Applied Dna Sciences APDN public float $11M, Mar 31, 2025, over 18 months old
  2. ZeroStack FLGC public float $11M, Jun 30, 2025
  3. Marblegate Capital MGTE public float $12M, Jun 30, 2025
  4. Marygold Companies MGLD public float $9M, Dec 31, 2025
  5. Beneficient BENF public float $9M, Sep 30, 2025